Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(PBRM1). Showing records 1 – 4 of 4 total matches.

Search Limiters

Last 2 Years | English Only

No search limiters apply to these results.

▼ Search Limiters

1. Högner, Anica. Role of the tumor suppressor genes PBRM1 and VHL in clear cell renal cell carcinogenesis.

Degree: 2018, Freie Universität Berlin

 Background In clear cell renal cell carcinoma (ccRCC), PBRM1 (Polybromo-1 gene) harbors about 40% truncating somatic mutations and was identified as the second most frequently… (more)

Subjects/Keywords: PBRM1; VHL; Immunohistochemistry; Tissue microarray; Clear cell renal cell carcinoma; 600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit

…Andreas Erbersdobler, Andreas Patzak, Ergin Kilic „PBRM1 and VHL expression correlate in human… …Einzelnen: Die gemeinsame Projekt-Idee für die Untersuchung des Tumorsuppressorgens PBRM1 im… …PBRM1 zu entwickeln, welches zunächst die histologische Expression von PBRM1 und VHL auf… …etablierte das PBRM1- und VHL -Färbeprotokoll im Institut für Vegetative Physiologie der Charité… …Expressionsstärke von PBRM1 und VHL. Über das Institut für Pathologie bekam ich die Möglichkeit, 14 Tissue… 

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Högner, A. (2018). Role of the tumor suppressor genes PBRM1 and VHL in clear cell renal cell carcinogenesis. (Thesis). Freie Universität Berlin. Retrieved from http://dx.doi.org/10.17169/refubium-1401

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Högner, Anica. “Role of the tumor suppressor genes PBRM1 and VHL in clear cell renal cell carcinogenesis.” 2018. Thesis, Freie Universität Berlin. Accessed April 14, 2021. http://dx.doi.org/10.17169/refubium-1401.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Högner, Anica. “Role of the tumor suppressor genes PBRM1 and VHL in clear cell renal cell carcinogenesis.” 2018. Web. 14 Apr 2021.

Vancouver:

Högner A. Role of the tumor suppressor genes PBRM1 and VHL in clear cell renal cell carcinogenesis. [Internet] [Thesis]. Freie Universität Berlin; 2018. [cited 2021 Apr 14]. Available from: http://dx.doi.org/10.17169/refubium-1401.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Högner A. Role of the tumor suppressor genes PBRM1 and VHL in clear cell renal cell carcinogenesis. [Thesis]. Freie Universität Berlin; 2018. Available from: http://dx.doi.org/10.17169/refubium-1401

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Michigan Technological University

2. Hopson, Sarah. Heterologous Expression and Purification of Full-Length Human Polybromo-1 Protein.

Degree: PhD, Department of Chemistry, 2017, Michigan Technological University

  Over the past decade, it has become apparent that the human polybromo-1 protein (BAF180) has a critical role in cancer. BAF180 is known to… (more)

Subjects/Keywords: recombinant protein expression and purification; human polybromo-1; BAF180; PBRM1; hPB1; Pichia pastoris; Biochemistry; Molecular Biology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hopson, S. (2017). Heterologous Expression and Purification of Full-Length Human Polybromo-1 Protein. (Doctoral Dissertation). Michigan Technological University. Retrieved from https://digitalcommons.mtu.edu/etdr/436

Chicago Manual of Style (16th Edition):

Hopson, Sarah. “Heterologous Expression and Purification of Full-Length Human Polybromo-1 Protein.” 2017. Doctoral Dissertation, Michigan Technological University. Accessed April 14, 2021. https://digitalcommons.mtu.edu/etdr/436.

MLA Handbook (7th Edition):

Hopson, Sarah. “Heterologous Expression and Purification of Full-Length Human Polybromo-1 Protein.” 2017. Web. 14 Apr 2021.

Vancouver:

Hopson S. Heterologous Expression and Purification of Full-Length Human Polybromo-1 Protein. [Internet] [Doctoral dissertation]. Michigan Technological University; 2017. [cited 2021 Apr 14]. Available from: https://digitalcommons.mtu.edu/etdr/436.

Council of Science Editors:

Hopson S. Heterologous Expression and Purification of Full-Length Human Polybromo-1 Protein. [Doctoral Dissertation]. Michigan Technological University; 2017. Available from: https://digitalcommons.mtu.edu/etdr/436

3. Morel, Daphné. Identifying Synthetic Lethal and Selective Approaches to Target PBRM1-Deficiency in Clear Cell Renal Cell Carcinoma : Exploration de stratégies thérapeutiques ciblant la déficience en PBRM1 dans les carcinomes rénaux à cellules claires.

Degree: Docteur es, Aspects moléculaires et cellulaires de la biologie, 2020, université Paris-Saclay

L’inactivation de polybromo-1 (PBRM1) est un évènement fréquent dans de nombreux cancers. En particulier, les carcinomes rénaux à cellules claires présentent une déficience en PBRM1(more)

Subjects/Keywords: Pbrm1; Létalité synthétique; Inhibiteurs de PARP; Cancer du rein; Kidney cancer; Synthetic lethality; PARP inhibitors; Pbrm1

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Morel, D. (2020). Identifying Synthetic Lethal and Selective Approaches to Target PBRM1-Deficiency in Clear Cell Renal Cell Carcinoma : Exploration de stratégies thérapeutiques ciblant la déficience en PBRM1 dans les carcinomes rénaux à cellules claires. (Doctoral Dissertation). université Paris-Saclay. Retrieved from http://www.theses.fr/2020UPASL017

Chicago Manual of Style (16th Edition):

Morel, Daphné. “Identifying Synthetic Lethal and Selective Approaches to Target PBRM1-Deficiency in Clear Cell Renal Cell Carcinoma : Exploration de stratégies thérapeutiques ciblant la déficience en PBRM1 dans les carcinomes rénaux à cellules claires.” 2020. Doctoral Dissertation, université Paris-Saclay. Accessed April 14, 2021. http://www.theses.fr/2020UPASL017.

MLA Handbook (7th Edition):

Morel, Daphné. “Identifying Synthetic Lethal and Selective Approaches to Target PBRM1-Deficiency in Clear Cell Renal Cell Carcinoma : Exploration de stratégies thérapeutiques ciblant la déficience en PBRM1 dans les carcinomes rénaux à cellules claires.” 2020. Web. 14 Apr 2021.

Vancouver:

Morel D. Identifying Synthetic Lethal and Selective Approaches to Target PBRM1-Deficiency in Clear Cell Renal Cell Carcinoma : Exploration de stratégies thérapeutiques ciblant la déficience en PBRM1 dans les carcinomes rénaux à cellules claires. [Internet] [Doctoral dissertation]. université Paris-Saclay; 2020. [cited 2021 Apr 14]. Available from: http://www.theses.fr/2020UPASL017.

Council of Science Editors:

Morel D. Identifying Synthetic Lethal and Selective Approaches to Target PBRM1-Deficiency in Clear Cell Renal Cell Carcinoma : Exploration de stratégies thérapeutiques ciblant la déficience en PBRM1 dans les carcinomes rénaux à cellules claires. [Doctoral Dissertation]. université Paris-Saclay; 2020. Available from: http://www.theses.fr/2020UPASL017

4. Mota, Sara Teixeira Soares. Expressão diferencial do gene PBRM1 e sua qualificação clínica em tumores de próstata.

Degree: 2017, Federal University of Uberlândia

CNPq - Conselho Nacional de Desenvolvimento Científico e Tecnológico

O Câncer de Próstata (CaP) é o sexto tipo de câncer mais comum e mais dominante… (more)

Subjects/Keywords: CNPQ::CIENCIAS BIOLOGICAS::GENETICA; CNPQ::CIENCIAS BIOLOGICAS::GENETICA::GENETICA HUMANA E MEDICA; Câncer de próstata; PBRM1; Expressão diferencial; AR; Remodelagem da cromatina; Prostate Cancer; Differential expression; Remodeling complex; Genética; Próstata - câncer; Biomarcadores tumorais; Cromatina

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Mota, S. T. S. (2017). Expressão diferencial do gene PBRM1 e sua qualificação clínica em tumores de próstata. (Masters Thesis). Federal University of Uberlândia. Retrieved from MOTA, Sara Teixeira Soares. Expressão diferencial do gene PBRM1 e sua qualificação clínica em tumores de próstata . 2018. 58 f. Dissertação (Mestrado em Genética e Bioquímica) - Universidade Federal de Uberlândia, Uberlândia, 2018. Disponível em: http://dx.doi.org/10.14393/ufu.di.2018.800 . ; https://repositorio.ufu.br/handle/123456789/22273 ; http://dx.doi.org/10.14393/ufu.di.2018.800

Chicago Manual of Style (16th Edition):

Mota, Sara Teixeira Soares. “Expressão diferencial do gene PBRM1 e sua qualificação clínica em tumores de próstata.” 2017. Masters Thesis, Federal University of Uberlândia. Accessed April 14, 2021. MOTA, Sara Teixeira Soares. Expressão diferencial do gene PBRM1 e sua qualificação clínica em tumores de próstata . 2018. 58 f. Dissertação (Mestrado em Genética e Bioquímica) - Universidade Federal de Uberlândia, Uberlândia, 2018. Disponível em: http://dx.doi.org/10.14393/ufu.di.2018.800 . ; https://repositorio.ufu.br/handle/123456789/22273 ; http://dx.doi.org/10.14393/ufu.di.2018.800.

MLA Handbook (7th Edition):

Mota, Sara Teixeira Soares. “Expressão diferencial do gene PBRM1 e sua qualificação clínica em tumores de próstata.” 2017. Web. 14 Apr 2021.

Vancouver:

Mota STS. Expressão diferencial do gene PBRM1 e sua qualificação clínica em tumores de próstata. [Internet] [Masters thesis]. Federal University of Uberlândia; 2017. [cited 2021 Apr 14]. Available from: MOTA, Sara Teixeira Soares. Expressão diferencial do gene PBRM1 e sua qualificação clínica em tumores de próstata . 2018. 58 f. Dissertação (Mestrado em Genética e Bioquímica) - Universidade Federal de Uberlândia, Uberlândia, 2018. Disponível em: http://dx.doi.org/10.14393/ufu.di.2018.800 . ; https://repositorio.ufu.br/handle/123456789/22273 ; http://dx.doi.org/10.14393/ufu.di.2018.800.

Council of Science Editors:

Mota STS. Expressão diferencial do gene PBRM1 e sua qualificação clínica em tumores de próstata. [Masters Thesis]. Federal University of Uberlândia; 2017. Available from: MOTA, Sara Teixeira Soares. Expressão diferencial do gene PBRM1 e sua qualificação clínica em tumores de próstata . 2018. 58 f. Dissertação (Mestrado em Genética e Bioquímica) - Universidade Federal de Uberlândia, Uberlândia, 2018. Disponível em: http://dx.doi.org/10.14393/ufu.di.2018.800 . ; https://repositorio.ufu.br/handle/123456789/22273 ; http://dx.doi.org/10.14393/ufu.di.2018.800

.